ICSE China to Offer Inaugural Conference Programme in 2011

AMSTERDAM, May 3, 2011 - Leading events organiser UBM Live (www.ubmlive.com) today
announced details of the 2011 edition of ICSE China, which is dedicated to
pharmaceutical contract services and outsourcing. ICSE, hosted from
June 21-23, 2011 at the SNIEC China, is part of the most international
pharmaceutical events line-up in China, which includes CPhI China for
pharmaceutical ingredients, P-MEC China for pharma machinery and equipment,
BioPh China for the biopharmaceuticals market and the new LABWorld pavilion
for laboratory, analytical and biotechnology instrumentation technologies.
Over 2,000 exhibitors and 27,000 visitors are expected over the three days.
Attendance to the events is free through pre-registration at
www.cphi-china.com.

"China's domestic market is expected to overtake Japan and become the
world's second drug market by 2015(1)," noted Haf Cennydd, Brand Director,
ICSE, P-MEC China and BioPh China. She further noted, "This continued growth
has translated into continuously improving results for our events and has
enabled us to constantly evolve our brands to reflect market trends. For this
year's events we are excited to introduce a conference programme which will
add even greater value for our visitors."

The inaugural China conference series, titled "Pharma R&D and
Collaboration Strategies", will address global pharmaceutical issues, with an
emphasis on China's pharma market, across key areas such as New Drug
Discovery, Biopharm, Biosimilars, CRO/CMO, API Sourcing, Generics and Export
Strategies and more. It will bring together Chinese and global pharma
companies to explore different views regarding the China pharmaceutical
market. Thirty eminent speakers from international pharmaceutical companies
and research institutes, such as the FDA, Novartis, USP-China, Roche R&D
Center, GSK China/HK, AstraZeneca Innovation Centre China, sanofi-aventis,
REVA PHARMA, Dr. Reddy's and Shanghai Pharma, will share their knowledge and
research strategies. Additionally, in-depth case studies covering R&D and
business development strategies will be presented by an outstanding panel of
Chinese, Indian and international speakers from industry leading companies
and associations.

The introduction of the conference programme to the China events follows
the successful launch of a similar series at the CPhI Worldwide, CPhI South
America and CPhI India events and is expected to draw over 400 attendees. The
series will be offered in seven individually bookable 3-hour modules and
further information can be found at: www.cphichina-conference.com.

ICSE China offers a meeting place for major Chinese contract research
organizations (CRO) and contract manufacturing organizations (CMO). By
partnering with the co-located events, ICSE looks to offer comprehensive
industry access within the growing Chinese pharma market. Currently, contract
services and outsourcing are booming sectors in the Chinese pharma market.
Suppliers within this market have been able to successfully identify new
areas for expansion in both the domestic and global markets and ICSE and
co-located events provide face-to-face access to this growing market. The
synergy between the events further serves to improve the visitor experience
during the time spent in Shanghai.

The annual schedule of global ICSE events also includes ICSE Japan
(13-15, July, 2011, Intex Osaka Exhibition Centre, Osaka, Japan), ICSE South
America (24-26, August, 2011, Transamerica Expo Center, Sao Paola, Brazil),
ICSE (25-27, October, Messe Frankfurt, Germany), and ICSE India (30
November - 2 December, 2011, Bombay Exhibition Centre, Mumbai, India).
Further information about ICSE and its co-located events can be found online
At www.icsexpo.com, www.cphi.com, www.p-mec.com and
www.bioph-online.com.

(1) ARC China December 4, 2010 Newsletter

Notes for Editors:

    - With offices in the UK, Netherlands, USA, UAE and Brazil, UBM Live
      operates a number of market leading exhibitions, awards,
      websites/online products and publications in twenty different business
      sectors. UBM Live is part of UBM Ltd, a leading global media company
      listed on the London Stock Exchange. See www.ubmlive.com

    - UBM Ltd is a leading global business media company. We inform markets
      and bring the world's buyers and sellers together at events, online, in
      print and provide them with the information they need to do business
      successfully. Our 6,000 staff in more than 30 countries are organised
      into specialist teams that serve these communities, helping them to do
      business and their markets to work effectively and efficiently. See
      http;//www.ubm.com

Impress PR, Global (excl. North America): Richard Kerns, richard at impress-pr.com, +44-161-728-5880; North America: Beth Willers, beth at impress-pr.com, +1-503-928-7828; UBM Live, Ian O'Malley (ICSE, P-MEC, BioPh, LABWorld), +31-20-40-99-5526